Comparing engage with PST in late-life major depression: a preliminary report.
Comparing engage with PST in late-life major depression: a preliminary report.
复制标题
DOI:
10.1016/j.jagp.2014.06.008
复制
发表时间:
2015-05
影响因子:
7.2
通讯作者:
Arean, Patricia A.
中科院分区:
文献类型:
--
作者:
Alexopoulos, George S.;Raue, Patrick J.;Kiosses, Dimitris N.;Seirup, Joanna K.;Banerjee, Samprit;Arean, Patricia A.
The complexity of psychotherapies has been a barrier to community implementation. We used the Research Domain Criteria consensus as a guide to develop Engage, a streamlined, neurobiology-based psychotherapy for late-life depression that may match the skill set of practicing clinicians. This proof of concept study tested the hypotheses that Engage is bioequivalent to Problem Solving Therapy (PST) in reducing depressive symptoms, inducing remission, and ameliorating disability. Engage assumes that abnormal function of the positive valence systems fuels depression and uses “reward exposure” (engagement in meaningful, rewarding activities) as its principal intervention. Negativity bias, apathy, and emotional dysregulation are expressions of abnormalities in the negative valence, arousal and regulatory, and cognitive control systems respectively. Engage targets each of them with simple interventions only if they interfere with reward exposure. We treated openly with 9 weekly sessions of Engage 39 older adults with unipolar major depression. We compared their course of depression (HAM-D), remission rate (HAM-D<10), and disability (WHODAS) with those of a historical comparison group (N=97) treated with 9 weekly sessions of PST. Community social workers and research therapists required one third as much training time in Engage as in PST. Engage was non-inferior to PST in reducing HAM-D and WHODAS. Remission rates for Engage at 6 and 9 weeks were 18.2%, and 41.1%. The corresponding figures for PST were 13.7% and 35.0%. These initial observations suggest that Engage has comparable efficacy with PST in reducing depressive symptoms and disability and warrants a randomized controlled trial.
登录
查看更多内容
DOI:
10.1176/appi.ajp.2008.08081201
发表时间:
2009-06
期刊:
The American journal of psychiatry
影响因子:
--
作者:
Pizzagalli DA;Holmes AJ;Dillon DG;Goetz EL;Birk JL;Bogdan R;Dougherty DD;Iosifescu DV;Rauch SL;Fava M
通讯作者:
Fava M
DOI:
10.1186/1748-5908-4-50
发表时间:
2009-08-07
期刊:
Implementation science : IS
影响因子:
--
作者:
Damschroder LJ;Aron DC;Keith RE;Kirsh SR;Alexander JA;Lowery JC
通讯作者:
Lowery JC
影响因子:
3.7
作者:
Maier S;Szalkowski A;Kamphausen S;Perlov E;Feige B;Blechert J;Philipsen A;van Elst LT;Kalisch R;Tüscher O
通讯作者:
Tüscher O
影响因子:
6.6
作者:
Alexopoulos, George S.;Hoptman, Matthew J.;Yuen, Genevieve;Kanellopoulos, Dora;Seirup, Joanna K.;Lim, Kelvin O.;Gunning, Faith M.
通讯作者:
Gunning, Faith M.
影响因子:
--
作者:
Alexopoulos, George S.;Raue, Patrick J.;Kiosses, Dimitris N.;Mackin, R. Scott;Kanellopoulos, Dora;McCulloch, Charles;Arean, Patricia A.
通讯作者:
Arean, Patricia A.